Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype. - Archive ouverte HAL Access content directly
Journal Articles Cancer Letters Year : 2006

Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype.

(1) , (1) , (1) , (2) , (3) , (1) , (1)
1
2
3

Abstract

Pretherapeutic determination of tumor resistance to chemotherapy is a main challenge, hindered by the low number of mechanisms characterized at the same time, the small size of the clinical specimens and the heterogeneity of the techniques or the lack of true quantification. The aim of the present study was to determine in real time quantitative RT-PCR, tumor cell expression of several transcripts involved in cancer cell resistance with a unique cDNA sample from a tumor biopsy. The technique had to be suitable in clinical practice for determination of several factors involved in resistance to a given drug family, for example, fluoropyrimidines resistance factors: thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine kinase (TK), dihydrofolate reductase (DHFR), folylpolyglutamate synthetase (FPGS). A frame-shifted artificial construct was designed specifically to work within the same conditions. We validated our technique by quantifying expressions of these 5 genes starting from tissue samples of colorectal carcinoma and the surrounding normal mucosa of 33 different patients. That real time quantitative RT-PCR technique using the frame-shifted artificial construct as a standard provided a real comparison and quantification of different resistance factors. Tumor resistance phenotype determination based on that approach will be investigated in a control study.
Fichier principal
Vignette du fichier
CAN-D-05-00452.pdf (977.32 Ko) Télécharger le fichier
Vignette du fichier
inserm-00381692_edited.pdf (869.14 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00381692 , version 1 (23-06-2009)

Identifiers

Cite

Maud Barbado, Laurence Preisser, Michele Boisdron-Celle, Veronique Verriele, Gerard Lorimier, et al.. Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype.. Cancer Letters, 2006, 242 (2), pp.168-79. ⟨10.1016/j.canlet.2005.11.008⟩. ⟨inserm-00381692⟩
221 View
589 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More